Teknova to Report First Quarter 2025 Financial Results on May 8, 2025
Teknova (Nasdaq: TKNO), a leading producer of critical reagents for therapy, vaccine, and molecular diagnostics development, has scheduled its first quarter 2025 financial results announcement for May 8, 2025, after market close. The company will host a webcast and conference call at 5 p.m. Eastern Time on the same day. Interested participants can access the webcast through Teknova's Investor Relations section and must register to receive a unique PIN for dial-in access. A replay will be available on the company's website approximately two hours after the event.
Teknova (Nasdaq: TKNO), uno dei principali produttori di reagenti essenziali per lo sviluppo di terapie, vaccini e diagnostica molecolare, ha programmato la pubblicazione dei risultati finanziari del primo trimestre 2025 per il 8 maggio 2025, dopo la chiusura del mercato. La società terrà una webcast e una conference call alle 17:00 ora Eastern dello stesso giorno. Gli interessati potranno accedere alla webcast tramite la sezione Investor Relations di Teknova e dovranno registrarsi per ricevere un PIN univoco per l’accesso telefonico. La registrazione sarà disponibile sul sito web dell’azienda circa due ore dopo l’evento.
Teknova (Nasdaq: TKNO), un productor líder de reactivos críticos para el desarrollo de terapias, vacunas y diagnóstico molecular, ha programado el anuncio de sus resultados financieros del primer trimestre de 2025 para el 8 de mayo de 2025, después del cierre del mercado. La empresa realizará una transmisión en vivo y una conferencia telefónica a las 5 p.m., hora del Este, el mismo día. Los interesados podrán acceder a la transmisión a través de la sección de Relaciones con Inversionistas de Teknova y deberán registrarse para recibir un PIN único para el acceso telefónico. La repetición estará disponible en la página web de la compañía aproximadamente dos horas después del evento.
Teknova (나스닥: TKNO)는 치료제, 백신 및 분자 진단 개발에 필수적인 시약의 선도 제조업체로서, 2025년 1분기 재무 실적 발표를 2025년 5월 8일 장 마감 후에 예정하고 있습니다. 회사는 같은 날 동부 표준시 오후 5시에 웹캐스트와 컨퍼런스 콜을 진행할 예정입니다. 관심 있는 참가자는 Teknova 투자자 관계 섹션을 통해 웹캐스트에 접속할 수 있으며, 전화 접속을 위한 고유 PIN을 받기 위해 등록해야 합니다. 이벤트 약 2시간 후 회사 웹사이트에서 다시보기 서비스를 이용할 수 있습니다.
Teknova (Nasdaq : TKNO), un leader dans la production de réactifs essentiels pour le développement de thérapies, vaccins et diagnostics moléculaires, a programmé l'annonce de ses résultats financiers du premier trimestre 2025 pour le 8 mai 2025, après la clôture du marché. La société organisera une webdiffusion et une conférence téléphonique à 17h00, heure de l’Est, le même jour. Les participants intéressés pourront accéder à la webdiffusion via la section Relations Investisseurs de Teknova et devront s’inscrire pour recevoir un code PIN unique permettant l’accès par téléphone. Une rediffusion sera disponible sur le site internet de l’entreprise environ deux heures après l’événement.
Teknova (Nasdaq: TKNO), ein führender Hersteller kritischer Reagenzien für die Entwicklung von Therapien, Impfstoffen und molekularer Diagnostik, hat die Veröffentlichung der Finanzergebnisse für das erste Quartal 2025 für den 8. Mai 2025 nach Börsenschluss geplant. Das Unternehmen wird am selben Tag um 17 Uhr Eastern Time eine Webcast-Übertragung und eine Telefonkonferenz veranstalten. Interessierte Teilnehmer können über den Investor-Relations-Bereich von Teknova auf den Webcast zugreifen und müssen sich registrieren, um eine individuelle PIN für den Telefonzugang zu erhalten. Eine Aufzeichnung wird etwa zwei Stunden nach der Veranstaltung auf der Unternehmenswebseite verfügbar sein.
- None.
- None.
HOLLISTER, Calif., April 24, 2025 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today announced that the Company will report its financial results for the first quarter ended March 31, 2025, on Thursday, May 8, 2025, following the close of market.
Teknova will host a webcast and conference call on Thursday, May 8, 2025, beginning at 5 p.m. Eastern Time. To access the live webcast, listeners can log onto the call from the Investor Relations section of the Teknova website or by using this link. If you would like to participate in the call, please register for the webcast here to receive a unique PIN number and dial-in information. The webcast will be available for replay on the Company’s website approximately two hours after the event.
About Teknova
Teknova makes solutions possible. Since 1996, Teknova has been innovating the manufacture of critical reagents for the life sciences industry to accelerate the discovery and development of novel breakthroughs that will help people live longer, healthier lives. We offer fully customizable solutions for every stage of the workflow, supporting industry leaders in molecular diagnostics, synthetic biology, and emerging therapeutic modalities. Our fast turnaround of high-quality agar plates, microbial culture media, buffers and reagents, and water helps our customers scale seamlessly from RUO to GMP. Headquartered in Hollister, California, with over 180,000 square feet of state-of-the-art facilities, Teknova’s modular manufacturing platform was designed by our team of scientists, engineers, and quality control experts to efficiently produce the foundational ingredients for the discovery and commercialization of next-generation therapies.
Investor Contact
Matt Lowell
Chief Financial Officer
matt.lowell@teknova.com
+1 831-637-1100
Media Contact
Jennifer Henry
Senior Vice President, Marketing
jenn.henry@teknova.com
+1 831-313-1259
This press release was published by a CLEAR® Verified individual.
FAQ
When will Teknova (TKNO) release Q1 2025 earnings?
How can investors join Teknova's (TKNO) Q1 2025 earnings call?
What time is Teknova's (TKNO) Q1 2025 earnings call?
Will there be a replay available for Teknova's (TKNO) Q1 2025 earnings call?
